Evidence for a mouse origin of the SARS-CoV-2 Omicron variant
SARS-CoV-2 Omicron 变体来源于小鼠的证据
SARS-CoV-2オミクロン変異体のマウス起源の証拠
SARS-CoV-2 오미크론 변이체의 마우스 기원에 대한 증거
Evidencia de un origen de ratón de la variante Omicron SARS-CoV-2
Preuve d'une origine murine de la variante SARS-CoV-2 Omicron
Доказательства мышиного происхождения варианта SARS-CoV-2 Omicron
¹ State Key Laboratory of Plant Genomics, Institute of Genetics and Developmental Biology, Innovation Academy for Seed Design, Chinese Academy of Sciences, Beijing 100101, China
中国 北京 中国科学院种子创新研究院 遗传与发育生物学研究所 植物基因组学国家重点实验室
² University of Chinese Academy of Sciences, Beijing 100049, China
中国 北京 中国科学院大学
Journal of Genetics and Genomics, 25 December 2021
Abstract
The rapid accumulation of mutations in the SARS-CoV-2 Omicron variant that enabled its outbreak raises questions as to whether its proximal origin occurred in humans or another mammalian host. Here, we identified 45 point mutations that Omicron acquired since divergence from the B.1.1 lineage.
We found that the Omicron spike protein sequence was subjected to stronger positive selection than that of any reported SARS-CoV-2 variants known to evolve persistently in human hosts, suggesting a possibility of host-jumping. The molecular spectrum of mutations (i.e., the relative frequency of the 12 types of base substitutions) acquired by the progenitor of Omicron was significantly different from the spectrum for viruses that evolved in human patients, but resembled the spectra associated with virus evolution in a mouse cellular environment.
Furthermore, mutations in the Omicron spike protein significantly overlapped with SARS-CoV-2 mutations known to promote adaptation to mouse hosts, particularly through enhanced spike protein binding affinity for the mouse cell entry receptor.
Collectively, our results suggest that the progenitor of Omicron jumped from humans to mice, rapidly accumulated mutations conducive to infecting that host, then jumped back into humans, indicating an inter-species evolutionary trajectory for the Omicron outbreak.